Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCohen, Daniel Dylanspa
dc.contributor.authorLópez Jaramillo, Patriciospa
dc.contributor.authorLópez López, Josespa
dc.contributor.authorGaray, Jenniferspa
dc.contributor.authorWandurraga, Edwinspa
dc.contributor.authorCamacho López, Paul Anthonyspa
dc.contributor.authorHiguera Escalante, Fernandospa
dc.description.abstractGuidelines recommend early detection of type 2 diabetes mellitus (DM2). The objective of the present study was to evaluate the capacity to identify DM2 in subjects that were screened for DM2 simultaneously with all three of the tests recommended—fasting plasma glucose (FPG), glycosylated hemoglobin (HbA1c) and a 2-hour post 75-g oral glucose tolerance test (OGTT). Methods and results The present analysis of an anonymous database of 1113 adults from a reference clinical laboratory in Bucaramanga, Colombia, was an observational, descriptive, cross-sectional secondary source study. 259 individuals met at least one of the criteria for DM2: FPG 126mg/dL (7.0mmol/L), HbA1c 6.5% (48mmol/mol) and OGTT 200mg/dL (11.1mmol/L). 30 subjects (2.7%) were diabetic according to FPG, 56 subjects (5.0%) by HbA1c and 250 subjects (22.5%) by OGTT. In total 259 subjects (23.3% [IC 95%: 20.7%– 25.8%] were diabetic either by FPG, OGTT or HbA1c. Discussion The largest number of patients were identified as diabetic with the OGTT. The combination of two or three tests did not increase the detection of new cases of DM2. Our findings suggest that routinely requesting FPG, OGTT and HbA1c at the same time may be inappropriate in at risk individuals, as this approach does not significantly improve the diagnostic capacity compared to using FPG+OGTT and substantially increases the financial burden on the health system, insurers or individual.eng
dc.relation.ispartofRevista Mexicana de Ciencias Pecuariasspa
dc.rightsDerechos Reservados - Universidad de Santander, 2018spa
dc.titleThe simultaneous assessment of glycosylated hemoglobin, fasting plasma glucose and oral glucose tolerance test does not improve the detection of type 2 diabetes mellitus in Colombian adultseng
dc.typeArtículo de revistaspa
dc.rights.creativecommonsAtribución-NoComercial 4.0 Internacional (CC BY-NC 4.0)spa
dc.subject.proposalGlycosylated hemoglobineng
dc.subject.proposalType 2 diabetes mellituseng
Appears in Collections:DCABA. Artículos de Investigación

This item is licensed under a Creative Commons License Creative Commons